孤儿药称号-话题@MedSci - 梅斯（MedSci）

#孤儿药称号#

48篇内容 | 2374人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1365224, encodeId=ab80136522498, content=<a href='/topic/show?id=dfa045434e1' target=_blank style='color:#2F92EE;'>#孤儿药称号#</a>, objectTitle=Hanmi的NASH候选药物HM15211治疗硬化性胆管炎，获得FDA孤儿药称号, objectType=article, longId=189674, objectId=42571896e458, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42571896e458, replyNumber=0, likeNumber=81, createdTime=2020-03-12, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42571896e458, moduleTitle=Hanmi的NASH候选药物HM15211治疗硬化性胆管炎，获得FDA孤儿药称号, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=42571896e458)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365223, encodeId=df2f136522324, content=<a href='/topic/show?id=dfa045434e1' target=_blank style='color:#2F92EE;'>#孤儿药称号#</a>, objectTitle=Cytokinetics的快速骨骼肌肌钙蛋白激活剂Reldesemtiv获得欧洲孤儿药称号，用于治疗肌萎缩性侧索硬化症, objectType=article, longId=189514, objectId=6bd71895142a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6bd71895142a, replyNumber=0, likeNumber=55, createdTime=2020-03-08, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6bd71895142a, moduleTitle=Cytokinetics的快速骨骼肌肌钙蛋白激活剂Reldesemtiv获得欧洲孤儿药称号，用于治疗肌萎缩性侧索硬化症, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=6bd71895142a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365222, encodeId=6e3c13652220b, content=<a href='/topic/show?id=dfa045434e1' target=_blank style='color:#2F92EE;'>#孤儿药称号#</a>, objectTitle=FDA授予OTL-102孤儿药称号，用于治疗X连锁慢性肉芽肿（X-CGD）, objectType=article, longId=187030, objectId=a33918e03075, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a33918e03075, replyNumber=0, likeNumber=62, createdTime=2020-02-01, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a33918e03075, moduleTitle=FDA授予OTL-102孤儿药称号，用于治疗X连锁慢性肉芽肿（X-CGD）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a33918e03075)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365221, encodeId=86711365221a8, content=<a href='/topic/show?id=dfa045434e1' target=_blank style='color:#2F92EE;'>#孤儿药称号#</a>, objectTitle=化学疗法诱发的血小板减少症如何治疗？-FDA授予avatrombopag孤儿药称号, objectType=article, longId=185150, objectId=07e11851505d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=07e11851505d, replyNumber=0, likeNumber=53, createdTime=2019-12-26, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=07e11851505d, moduleTitle=化学疗法诱发的血小板减少症如何治疗？-FDA授予avatrombopag孤儿药称号, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=07e11851505d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365220, encodeId=b821136522036, content=<a href='/topic/show?id=dfa045434e1' target=_blank style='color:#2F92EE;'>#孤儿药称号#</a>, objectTitle=Zotiraciclib治疗胶质母细胞瘤被FDA和EMA授予孤儿药称号, objectType=article, longId=184383, objectId=59e518438304, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=59e518438304, replyNumber=0, likeNumber=78, createdTime=2019-12-09, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=59e518438304, moduleTitle=Zotiraciclib治疗胶质母细胞瘤被FDA和EMA授予孤儿药称号, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=59e518438304)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365219, encodeId=fdc1136521925, content=<a href='/topic/show?id=dfa045434e1' target=_blank style='color:#2F92EE;'>#孤儿药称号#</a>, objectTitle=复星医药新开发的白血病药物FN-1501获得FDA孤儿药称号, objectType=article, longId=183900, objectId=823f18390056, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=823f18390056, replyNumber=0, likeNumber=88, createdTime=2019-12-02, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=823f18390056, moduleTitle=复星医药新开发的白血病药物FN-1501获得FDA孤儿药称号, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=823f18390056)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365218, encodeId=a5331365218ff, content=<a href='/topic/show?id=dfa045434e1' target=_blank style='color:#2F92EE;'>#孤儿药称号#</a>, objectTitle=Minoryx公司的PPRP激动剂来瑞格列酮治疗Friedreich共济失调，获得FDA孤儿药称号, objectType=article, longId=181655, objectId=22581816559a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=22581816559a, replyNumber=0, likeNumber=77, createdTime=2019-10-22, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=22581816559a, moduleTitle=Minoryx公司的PPRP激动剂来瑞格列酮治疗Friedreich共济失调，获得FDA孤儿药称号, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=22581816559a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365217, encodeId=ce3e136521ec9, content=<a href='/topic/show?id=dfa045434e1' target=_blank style='color:#2F92EE;'>#孤儿药称号#</a>, objectTitle=Verastem的PI3K抑制剂COPIKTRA治疗T细胞淋巴瘤，获得FDA的孤儿药称号, objectType=article, longId=180514, objectId=7f23180514e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f23180514e5, replyNumber=0, likeNumber=65, createdTime=2019-10-06, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f23180514e5, moduleTitle=Verastem的PI3K抑制剂COPIKTRA治疗T细胞淋巴瘤，获得FDA的孤儿药称号, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=7f23180514e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

孤儿药称号

2020-05-29

huiwelcome (审核中...)

前往app查看评论内容

#孤儿药称号#

Hanmi的NASH候选药物HM15211治疗硬化性胆管炎，获得FDA孤儿药称号

2020-03-12

huiwelcome (审核中...)

前往app查看评论内容

#孤儿药称号#

Cytokinetics的快速骨骼肌肌钙蛋白激活剂Reldesemtiv获得欧洲孤儿药称号，用于治疗肌萎缩性侧索硬化症

2020-03-08

huiwelcome (审核中...)

前往app查看评论内容

#孤儿药称号#

FDA授予OTL-102孤儿药称号，用于治疗X连锁慢性肉芽肿（X-CGD）

2020-02-01

huiwelcome (审核中...)

前往app查看评论内容

#孤儿药称号#

化学疗法诱发的血小板减少症如何治疗？-FDA授予avatrombopag孤儿药称号

2019-12-26

huiwelcome (审核中...)

前往app查看评论内容

#孤儿药称号#

Zotiraciclib治疗胶质母细胞瘤被FDA和EMA授予孤儿药称号

2019-12-09

huiwelcome (审核中...)

前往app查看评论内容

#孤儿药称号#

复星医药新开发的白血病药物FN-1501获得FDA孤儿药称号

2019-12-02

huiwelcome (审核中...)

前往app查看评论内容

#孤儿药称号#

Minoryx公司的PPRP激动剂来瑞格列酮治疗Friedreich共济失调，获得FDA孤儿药称号

2019-10-22

huiwelcome (审核中...)

前往app查看评论内容

#孤儿药称号#

Verastem的PI3K抑制剂COPIKTRA治疗T细胞淋巴瘤，获得FDA的孤儿药称号

2019-10-06

科室
- - 订阅+
  - 更多科室
工具
服务